CN110292616A - The pharmaceutical composition and its application method for treating arthralgia and myalgia - Google Patents
The pharmaceutical composition and its application method for treating arthralgia and myalgia Download PDFInfo
- Publication number
- CN110292616A CN110292616A CN201910691850.3A CN201910691850A CN110292616A CN 110292616 A CN110292616 A CN 110292616A CN 201910691850 A CN201910691850 A CN 201910691850A CN 110292616 A CN110292616 A CN 110292616A
- Authority
- CN
- China
- Prior art keywords
- parts
- myalgia
- arthralgia
- pharmaceutical composition
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Insects & Arthropods (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a kind of pharmaceutical composition and its application method for treating arthralgia and myalgia, wherein, the pharmaceutical composition for treating arthralgia and myalgia is grouped as by the group of following parts by weight: 6-10 parts of safflower, 5-9 parts of lycopodium calvatum, 7-11 parts of lopseed, 4-6 parts of folium artemisiae argyi, 8-12 parts of Caulis Spatholobi, 9-15 parts of radix cyathulae, 9-15 parts of teasel, 10-16 parts of ramulus cinnamomi, 8-12 parts of corydalis tuber, 12-18 parts of Rhizoma Chuanxiong, 12-18 parts of myrrh, 8-12 parts of asarum, 10-16 parts of ground beetle, 15-21 parts of olibanum, 12-18 parts of monkshood, 12-18 parts of the rhizome of davallia and 50-200 parts of yellow rice wine.Technical solution of the present invention side effect is smaller and can be applicable in the pharmaceutical composition of a variety for the treatment of arthralgia and myalgias of arthralgia and myalgia caused by many reasons.
Description
Technical field
The present invention relates to lunar physics technique field, in particular to a kind of pharmaceutical composition for treating arthralgia and myalgia and its user
Method.
Background technique
In the cognition of traditional Chinese medical science field, muscles and bones is the main portions of human body, and liver governing tendons, Shen controls bone, liver kidney is human body
In lower coke, account for 2/3rds in three cokes, it is seen that importance of the muscles and bones in human body.Arthralgia and myalgia is a kind of common muscles and bones disease,
It may be the prescription for some treatment arthralgia and myalgias that circulate on the market at present, wherein common since rheumatism, strain, injury cause
The externally applied drug for having lignum sappan and sea otter compatibility, the externally applied drug of monkshood and pheretima compatibility, the externally applied drug of tripterygium wilfordii and centipede compatibility,
Using dragon's blood as the externally applied drug of main composition, using erythrina bark as the externally applied drug of main composition.In those prescriptions, lignum sappan
Mainly there is promoting circulation of blood with the lignum sappan of the externally applied drug of sea otter compatibility, married woman's pain in the chest and abdomen is controlled in detumescence, menostasis, analgesic, and sea otter
There are establishing-Yang, strong kidney, anti-aging, this side treats muscles and bones lumbocrural pain also by strong kidney simultaneously by promoting circulation of blood swelling and pain relieving
It is to have certain effect, but the lignum sappan in this side is not suitable for the deficiency of blood and pregnant woman uses, and sea otter is likely to cause skin scabies
The side effect of pain and gastrointestinal distress.In the externally applied drug of monkshood and pheretima compatibility monkshood play the role of in wet spleen sun, lower kidney-replenishing, and
Pheretima plays the role of reducing fever and causing diuresis, insane, clearing lung, relieving asthma, will not be too strong although good the effect of this prescription, meanwhile, monkshood has
Virulent, the bad of utilization will appear expiratory dyspnea, motor paralysis, the serious side effects such as nerve ending spasm, and pheretima also can sometimes
There are the side effects such as headache, nausea, the abnormal, allergic rash of blood pressure from low to high.In the prescription of tripterygium wilfordii and centipede compatibility,
Tripterygium wilfordii plays the role of dispelling wind and eliminating dampness, rheumatic arthritis, and centipede plays the role of relieving spasm by calming endogenous wind, removes obstruction in channels to relieve pain, this prescription is logical
Dispelling wind and eliminating dampness is crossed, clearing and activating the channels and collaterals, the effect to relieve the pain is ached to treat waist-leg, but tripterygium wilfordii is toxic, it sometimes appear that nausea,
The side effects such as vomiting, diarrhea, centipede be also it is toxic, also will appear diarrhea under some cases, palpitate quickly, under body temperature, blood pressure
The serious side effects such as drop.Mainly there are treatment traumatic injury, anti-inflammatory, hemostasis using dragon's blood as the dragon's blood of the externally applied drug of main composition
The effect of myogenic, by diminishing inflammation, the mode of myogenic hemostasis, to treat arthralgia and myalgia, still, dragon's blood is toxic, some cases
Under will appear the side effects such as allergy, body itch flush, angioedema.Using erythrina bark as the external application of main composition
Medicine, erythrina bark mainly play the role of: desinsection analgesic, decayed tooth pain, traumatic injury, this medicine mainly pass through the work of pain-alleviating and network vessel-freeing synthetism
For treating arthralgia and myalgia, but the people that erythrina bark is not suitable for the deficiency of blood uses, while non-rheumatic lumbago should not also use.It can be seen that
Chinese medicine preparation has larger side effect at present, and can not be applicable in arthralgia and myalgia caused by many reasons.
Summary of the invention
The main object of the present invention is to provide a kind of side effect compared with small and to be applicable in arthralgia and myalgia caused by many reasons more
The pharmaceutical composition of kind treatment arthralgia and myalgia.
To achieve the above object, it is proposed by the present invention treatment arthralgia and myalgia pharmaceutical composition by following parts by weight component
Composition:
6-10 parts of safflower, 5-9 parts of lycopodium calvatum, 7-11 parts of lopseed, 4-6 parts of folium artemisiae argyi, 8-12 parts of Caulis Spatholobi, radix cyathulae 9-15
Part, 9-15 parts of teasel, 10-16 parts of ramulus cinnamomi, 8-12 parts of corydalis tuber, 12-18 parts of Rhizoma Chuanxiong, 12-18 parts of myrrh, 8-12 parts of asarum, soil
10-16 parts of soft-shelled turtle, 15-21 parts of olibanum, 12-18 parts of monkshood, 12-18 parts of the rhizome of davallia and 50-200 parts of yellow rice wine.
Preferably, the pharmaceutical composition of the treatment arthralgia and myalgia is grouped as by the group of following parts by weight: safflower 7-9
Part, 6-8 parts of lycopodium calvatum, 8-10 parts of lopseed, 4-6 parts of folium artemisiae argyi, 9-11 parts of Caulis Spatholobi, 11-13 parts of radix cyathulae, teasel 11-13
Part, 13-14 parts of ramulus cinnamomi, 9-11 parts of corydalis tuber, 14-16 parts of Rhizoma Chuanxiong, 14-16 parts of myrrh, 9-11 parts of asarum, 12-14 parts of ground beetle, olibanum
17-19 parts, 14-16 parts of monkshood, 14-16 parts of the rhizome of davallia and 50-200 parts of yellow rice wine.
Preferably, the pharmaceutical composition of the treatment arthralgia and myalgia is grouped as by the group of following parts by weight: 8 parts of safflower,
7 parts of lycopodium calvatum, 9 parts of lopseed, 5 parts of folium artemisiae argyi, 10 parts of Caulis Spatholobi, 12 parts of radix cyathulae, 12 parts of teasel, 13 parts of ramulus cinnamomi, corydalis tuber 10
Part, 15 parts of Rhizoma Chuanxiong, 15 parts of myrrh, 10 parts of asarum, 13 parts of ground beetle, 18 parts of olibanum, 15 parts of monkshood, 15 parts of the rhizome of davallia and yellow rice wine
50-100 parts.
Preferably, the pharmaceutical composition of the treatment arthralgia and myalgia is grouped as by the group of following parts by weight: 9 parts of safflower,
8 parts of lycopodium calvatum, 9 parts of lopseed, 5 parts of folium artemisiae argyi, 10 parts of Caulis Spatholobi, 12 parts of radix cyathulae, 12 parts of teasel, 13 parts of ramulus cinnamomi, corydalis tuber 12
Part, 15 parts of Rhizoma Chuanxiong, 16 parts of myrrh, 10 parts of asarum, 13 parts of ground beetle, 18 parts of olibanum, 15 parts of monkshood, 17 parts of the rhizome of davallia and yellow rice wine 70
Part.
Preferably, the safflower, the lycopodium calvatum, the lopseed, the folium artemisiae argyi, the Caulis Spatholobi, radix cyathulae, radix dipsaci
Continuous, ramulus cinnamomi, corydalis tuber, Rhizoma Chuanxiong, myrrh, asarum, ground beetle, olibanum, monkshood and the rhizome of davallia grind into powder after frying, it is described
Yellow rice wine infiltrates the powder.
The present invention also proposes a kind of application method of pharmaceutical composition for treating arthralgia and myalgia, by the treatment arthralgia and myalgia
Pharmaceutical composition apply into site of disease, wrapped up with hospital gauze, once a day, one time 8~12 hours.
Technical solution of the present invention is using Caulis Spatholobi, lycopodium calvatum, the rhizome of davallia, corydalis tuber as main component.The effect of Caulis Spatholobi
Be promoting circulation of blood enrich blood, menstruation regulating, relaxing tendons and activating collaterals, treat rheumatic arthralgia, quadriplegia.Lycopodium calvatum mainly have expelling wind and clearing away cold, relaxing tendons and activating collaterals,
Muscle arteries and veins contraction pain is treated in the effect of antibacterial.The rhizome of davallia, which can treat fracture, arthritis, antithrombotic, can also alleviate tinnitus.Corydalis tuber has
Regulating qi-flowing for relieving pain, promoting blood circulation scattered silt, treat the effect of traumatic injury.The compatibility of this prescription, by qi and blood circulation promotion, relaxing tendons and activating collaterals, wind-dispelling dissipates
It trembles with fear, antibacterial anti-inflammatory, a variety of effects such as analgesic cooperate muscles and bones lumbocrural pain caused by have the function that treat rheumatism and damage,
Meanwhile this formula utilization is all ingredient safe in Chinese medicine, directly good using fast effect is absorbed, external application does not have the secondary work of any poison
With can use safely.
The realization, the function and the advantages of the object of the present invention will in conjunction with the embodiments, and reference is described further.
Specific embodiment
The technical scheme in the embodiments of the invention will be clearly and completely described below, it is clear that described implementation
Example is only a part of the embodiments of the present invention, instead of all the embodiments.Based on the embodiments of the present invention, this field is general
Logical technical staff every other embodiment obtained without creative efforts belongs to what the present invention protected
Range.
The present invention proposes a kind of pharmaceutical composition for treating arthralgia and myalgia.The drug for the treatment of arthralgia and myalgia proposed by the present invention
Composition is grouped as by the group of following parts by weight:
6-10 parts of safflower, 5-9 parts of lycopodium calvatum, 7-11 parts of lopseed, 4-6 parts of folium artemisiae argyi, 8-12 parts of Caulis Spatholobi, radix cyathulae 9-15
Part, 9-15 parts of teasel, 10-16 parts of ramulus cinnamomi, 8-12 parts of corydalis tuber, 12-18 parts of Rhizoma Chuanxiong, 12-18 parts of myrrh, 8-12 parts of asarum, soil
10-16 parts of soft-shelled turtle, 15-21 parts of olibanum, 12-18 parts of monkshood, 12-18 parts of the rhizome of davallia and 50-200 parts of yellow rice wine.
Wherein, the effect of safflower has promoting blood circulation and removing obstruction in channels, stasis-dispelling and pain-killing；Cure mainly stasis, menostasis, dysmenorrhea, rear stasis of blood, chest
Numbness is pained, traumatic injury, the stagnant swelling and pain of the stasis of blood.
Folium artemisiae argyi property acrid, bitter, warm, returns liver,spleen,kidney to pass through；Warming channel for arresting bleeding is cured mainly, eliminating cold to stop pain controls pruitus outside.
Lycopodium calvatum property is sweet, pungent, warm, enters Liver Channel；Wind-cold-dampness arthralgia is cured mainly, tendon and vessel spasm pain, bruises and spasms are antibacterial,
Relaxing tendons and activating collaterals prevents senile dementia.
Lopseed property is sweet, pungent, warm, enters the warp of lung, liver；Dispelling wind and eliminating dampness, relaxing tendons and activating collaterals, eliminating stasis to subdue swelling, rheumatic arthralgia, muscles and bones
Contracture is sprained, paralysis.
Ramulus cinnamomi expelling cold and relieving exterior syndrome, warming meridians and promoting circulation of qi, the evil of rheumatism table, numbness and ache of cold dampness, thoracic obstruction palpitaition, the insufficiency of the kidney yang, lumbocrural pain.
Caulis Spatholobi can invigorate blood circulation, and relaxing muscles and tendons controls soreness of waist and knee joint, paralysis and numbness, hematopoiesis of enriching blood.
Radix cyathulae is sweet in flavor, slight bitter, mild-natured, returns liver and kidney channel；Can be easing joint movement, dispelling stasis of blood and stimulating the menstrual flow, inducing diuresis for treating strangurtia, arthralgia,
Sufficient impotence muscle contraction, traumatic injury.
Teasel: bitter, pungent, slightly warm in nature return liver and kidney channel.Blood vessels are adjusted in nourishing liver and kidney, strengthening the bones and muscles；Continuous injured；Only metrorrhagia and metrostaxis are used
In aching pain in waist and back, podomere flaccidity syndrome and arthralgia syndrome；Traumatic injury turns muscle folding bone.
It is corydalis tuber acrid flavour, hardship, warm-natured, return liver, kidney, lung, the heart, the spleen channel；Promoting blood circulation to remove blood stasis, regulating qi-flowing for relieving pain, the main all pains of trusted subordinate's waist and knee,
Irregular menstruation, injury from falling down.
Rhizoma Chuanxiong is pungent, warm, returns liver, gallbladder, the heart, Bao Jing；Wind-expelling pain-stopping, blood-activating and qi-promoting, pricking pain in the chest, fracture local hematoma are inhaled
It receives, it is calm, it is anti-inflammatory.
Do not have pharmacological property pungent, bitter, flat, returns liver, the heart, the spleen channel；Detumescence and promoting granulation, promoting blood circulation and stopping pain, to the stagnant pain of the stasis of blood, traumatic injury.
Asarum acrid flavour, returns liver and kidney channel；Wind-expelling pain-stopping, sensible opening and closing, antalgic preferably lead to swollen key.
Ground beetle property is salty, cold, return liver warp；Continuous muscles and bones break extravasated blood, to muscle liver injured.
Olibanum acrid, bitter, warm, return heart, liver, the spleen channel；Blood-activating and qi-promoting, inducing meastruation to relieve menalgia, detumescence and promoting granulation, bruise stasis caused pain, the main heart,
Abdomen pain.
Monkshood acrid flavour, hardship return liver, kidney, the heart, the spleen channel；Cold-dampness crymodynia is treated, arthralgia, the rhizome of Chinese monkshood is scorching and is good at stopping
Bitterly.
It is rhizome of davallia bitter, warm-natured, return liver and kidney channel；Traumatic injury, injured bones and muscles, the stagnant swelling and pain of the stasis of blood, swelling and pain relieving, continuous muscle connect
Bone enters kidney with it and controls bone, and energy treating bone fracture is broken and gains the name, thus section's key medicine.
Yellow rice wine smell is bitter, sweet, pungent；Can invigorate blood circulation dispelling cold, clearing and activating the channels and collaterals, facilitate blood circulation, boost metabolism, and can
Blood-enriching face-nourishing.
The compatibility of this prescription, by qi and blood circulation promotion, relaxing tendons and activating collaterals, expelling wind and clearing away cold, antibacterial anti-inflammatory, (corydalis tuber is also to use for analgesic
Than wide and safe analgesic drug products) etc. a variety of effects cooperation come reach treatment rheumatism and damage caused by arthralgia and myalgia
Effect, can be used for treating traumatic injury, fracture, strength vertebra disease, waist plead illness, the illnesss such as thoracic vertebrae disease, scapulohumeral periarthritis.Meanwhile this is formulated
What is used is all ingredient safe in Chinese medicine, and directly using absorbing, fast effect is good, and external application does not have any toxic side effect, can be safe
It uses.
In order to reach preferable effect, dosage can further be optimized, specifically, the treatment muscles and bones is ached
The pharmaceutical composition of pain is preferably grouped as by the group of following parts by weight: 7-9 parts of safflower, 6-8 parts of lycopodium calvatum, 8-10 parts of lopseed,
4-6 parts of folium artemisiae argyi, 9-11 parts of Caulis Spatholobi, 11-13 parts of radix cyathulae, 11-13 parts of teasel, 13-14 parts of ramulus cinnamomi, 9-11 parts of corydalis tuber, river
14-16 parts of rhizome of chuanxiong, 14-16 parts of myrrh, 9-11 parts of asarum, 12-14 parts of ground beetle, 17-19 parts of olibanum, 14-16 parts of monkshood, the rhizome of davallia
14-16 parts and 50-200 parts of yellow rice wine.
Safflower, the lycopodium calvatum, the lopseed, the folium artemisiae argyi, the Caulis Spatholobi, radix cyathulae, teasel, ramulus cinnamomi, member
Recklessly, Rhizoma Chuanxiong, myrrh, asarum, ground beetle, olibanum, monkshood and the rhizome of davallia through gathering medicinal herbs, clean, screening, drying, frying, storage
It forms uniform powdery after hiding, grinding, screening to be used as medicine, the diameter of powder is uniformly mixed preferably within two millimeters, is used
It is preceding that yellow rice wine is infiltrated into the mixed-powder.
Following two specific embodiment can be selected in actual use:
The pharmaceutical composition of preferred embodiment 1, the treatment arthralgia and myalgia is grouped as by the group of following parts by weight: safflower
8 parts, 7 parts of lycopodium calvatum, 9 parts of lopseed, 5 parts of folium artemisiae argyi, 10 parts of Caulis Spatholobi, 12 parts of radix cyathulae, 12 parts of teasel, 13 parts of ramulus cinnamomi, member
10 parts recklessly, 15 parts of Rhizoma Chuanxiong, 15 parts of myrrh, 10 parts of asarum, 13 parts of ground beetle, 18 parts of olibanum, 15 parts of monkshood, 15 parts of the rhizome of davallia and Huang
100 parts of wine.Every a specially 1 gram, preferred embodiment 1 can have preferable effect to rheumatism, traumatic injury, can be used as
Common prescription.
The pharmaceutical composition of preferred embodiment 2, the treatment arthralgia and myalgia is grouped as by the group of following parts by weight: safflower
9 parts, 8 parts of lycopodium calvatum, 9 parts of lopseed, 5 parts of folium artemisiae argyi, 10 parts of Caulis Spatholobi, 12 parts of radix cyathulae, 12 parts of teasel, 13 parts of ramulus cinnamomi, member
12 parts recklessly, 15 parts of Rhizoma Chuanxiong, 16 parts of myrrh, 10 parts of asarum, 13 parts of ground beetle, 18 parts of olibanum, 15 parts of monkshood, 17 parts of the rhizome of davallia and Huang
70 parts of wine.It is every it is a be specially 1 gram, 2 relative increase of preferred embodiment safflower, striker, myrrh, the rhizome of davallia dosage, can be with
It is preferably treated for traumatic injury, fracture etc., can be used as the optional formula of traumatic injury.
The present invention also proposes a kind of application method of pharmaceutical composition for treating arthralgia and myalgia, the medicine of the treatment arthralgia and myalgia
Pharmaceutical composition proposition of the application method of compositions for treatment arthralgia and myalgia of the invention, the medicine of the treatment arthralgia and myalgia
Compositions referring in particular to above-described embodiment, the following are the prescriptions of two embodiments 1 to use case, is illustrated with this using effect
Fruit.
Case 1: xx male, 22 years old, peasant.It is medical on October 2nd, 2018.
Check: right leg knee actuator current amplifier down swelling, pain, have wound capillary rupture, this disease is with deficiency of kidney-QI liver kidney yang
Void, blood-stasis internal-depression, with activating microcirculation and removing stasis medicinal normal circulation of qi and blood, yin yang complementarity, strengthening the muscles and bones, disease can fully recover.
Diagnosis: right leg open fracture of patella
Treatment: matched with the medicinal powder in the preferred embodiment 1 of the pharmaceutical composition of present invention treatment arthralgia and myalgia with yellow rice wine
It closes, applies into site of disease, bandaged with hospital gauze.Once a day, one time 10~12 hours, it is primary to control check in 7 days.
Check: Yu Shiyue 9 days is checked, and leg swelling and pain disappear, control to consolidate fracture healing by last time
Treatment method continued with one month, in order to avoid leaving sequelae, forbade taking exercise up and down during treatment.
Case 2: xx female Lee, 53 years old, peasant.It is medical on 2 5th, 2019
It checks: being Yaoyangkuan(Du 3) cave in waist fourth lumbar vertebra lower recess, feel by swelling and pain is pressed with, lumbar vertebrae keyboard protrusion is bright
Aobvious, head bends forward and holds high sore spot backward and becomes apparent from, and right leg is raised sore spot upwards and become apparent from, and injures waist because overworking, with
Eliminating evil dredging collateral, it is nourishing liver and kidney based on, tonification and purgation in combination for simulataneous insufficiency and excessive, make that passages through which vital energy circulates is unimpeded and qi and blood is harmonious and sore spot from only.
Diagnosis: protrusion of lumber intervertebral disc causes Sciatica
Treatment: matched with the medicinal powder in the preferred embodiment 1 of the pharmaceutical composition of present invention treatment arthralgia and myalgia with yellow rice wine
It closes and uses, apply into site of disease, bandaged with hospital gauze, once a day, one time 8~12 hours, it is primary to control check in 7 days.
Check: checking in 13 days 2 months, and pain reaction is unobvious, prevents overworked after curing, and prevents from losing after leaving
Disease forbade excessive exercise by last time method continual cure 7 days during treatment.
By above-mentioned two case as it can be seen that the pharmaceutical composition for the treatment of arthralgia and myalgia of the invention is easy to use, and pass through
The cooperation of qi and blood circulation promotion, relaxing tendons and activating collaterals, expelling wind and clearing away cold, antibacterial anti-inflammatory, a variety of effects such as analgesic is led to reach treatment rheumatism and damage
The effect of the muscles and bones lumbocrural pain of cause, it is significant in efficacy, and be free from side effects.
It it should be noted that the technical solution of each embodiment of the invention can be combined with each other, but must be with this
Based on the technical staff in field can be realized, when the combination of technical solution occur it is conflicting or when cannot achieve should people recognize
Combination for this technical solution is not present, also not the present invention claims protection scope within.
The above description is only a preferred embodiment of the present invention, is not intended to limit the scope of the invention, all utilizations
Equivalent structure transformation made by description of the invention and content is applied directly or indirectly in other relevant technical fields,
Similarly it is included within the scope of the present invention.
Claims (6)
1. a kind of pharmaceutical composition for treating arthralgia and myalgia, which is characterized in that be grouped as by the group of following parts by weight:
6-10 parts of safflower, 5-9 parts of lycopodium calvatum, 7-11 parts of lopseed, 4-6 parts of folium artemisiae argyi, 8-12 parts of Caulis Spatholobi, 9-15 parts of radix cyathulae,
9-15 parts of teasel, 10-16 parts of ramulus cinnamomi, 8-12 parts of corydalis tuber, 12-18 parts of Rhizoma Chuanxiong, 12-18 parts of myrrh, 8-12 parts of asarum, ground beetle
10-16 parts, 15-21 parts of olibanum, 12-18 parts of monkshood, 12-18 parts of the rhizome of davallia and 50-200 parts of yellow rice wine.
2. the pharmaceutical composition for the treatment of arthralgia and myalgia as described in claim 1, which is characterized in that by the component of following parts by weight
Composition:
7-9 parts of safflower, 6-8 parts of lycopodium calvatum, 8-10 parts of lopseed, 4-6 parts of folium artemisiae argyi, 9-11 parts of Caulis Spatholobi, 11-13 parts of radix cyathulae,
11-13 parts of teasel, 13-14 parts of ramulus cinnamomi, 9-11 parts of corydalis tuber, 14-16 parts of Rhizoma Chuanxiong, 14-16 parts of myrrh, 9-11 parts of asarum, ground beetle
12-14 parts, 17-19 parts of olibanum, 14-16 parts of monkshood, 14-16 parts of the rhizome of davallia and 50-200 parts of yellow rice wine.
3. the pharmaceutical composition for the treatment of arthralgia and myalgia as described in claim 1, which is characterized in that by the component of following parts by weight
Composition:
8 parts of safflower, 7 parts of lycopodium calvatum, 9 parts of lopseed, 5 parts of folium artemisiae argyi, 10 parts of Caulis Spatholobi, 12 parts of radix cyathulae, 12 parts of teasel, ramulus cinnamomi
13 parts, 10 parts of corydalis tuber, 15 parts of Rhizoma Chuanxiong, 15 parts of myrrh, 10 parts of asarum, 13 parts of ground beetle, 18 parts of olibanum, 15 parts of monkshood, the rhizome of davallia 15
Part and 50-100 parts of yellow rice wine.
4. the pharmaceutical composition for the treatment of arthralgia and myalgia as described in claim 1, which is characterized in that by the component of following parts by weight
Composition:
9 parts of safflower, 8 parts of lycopodium calvatum, 9 parts of lopseed, 5 parts of folium artemisiae argyi, 10 parts of Caulis Spatholobi, 12 parts of radix cyathulae, 12 parts of teasel, ramulus cinnamomi
13 parts, 12 parts of corydalis tuber, 15 parts of Rhizoma Chuanxiong, 16 parts of myrrh, 10 parts of asarum, 13 parts of ground beetle, 18 parts of olibanum, 15 parts of monkshood, the rhizome of davallia 17
Part and 70 parts of yellow rice wine.
5. the pharmaceutical composition for the treatment of arthralgia and myalgia according to any one of claims 1 to 4, which is characterized in that described red
Colored, the described lycopodium calvatum, the folium artemisiae argyi, the Caulis Spatholobi, radix cyathulae, teasel, ramulus cinnamomi, corydalis tuber, Rhizoma Chuanxiong, does not have the lopseed
Medicine, asarum, ground beetle, olibanum, monkshood and the rhizome of davallia grind into powder after frying, the yellow rice wine infiltrate the powder.
6. a kind of application method of the pharmaceutical composition for the treatment of arthralgia and myalgia as claimed in claim 5, which is characterized in that by institute
The pharmaceutical composition for stating treatment arthralgia and myalgia is applied into site of disease, is wrapped up with hospital gauze, once a day mono- time 8~12 hours.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910691850.3A CN110292616A (en) | 2019-07-30 | 2019-07-30 | The pharmaceutical composition and its application method for treating arthralgia and myalgia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910691850.3A CN110292616A (en) | 2019-07-30 | 2019-07-30 | The pharmaceutical composition and its application method for treating arthralgia and myalgia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110292616A true CN110292616A (en) | 2019-10-01 |
Family
ID=68032133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910691850.3A Pending CN110292616A (en) | 2019-07-30 | 2019-07-30 | The pharmaceutical composition and its application method for treating arthralgia and myalgia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110292616A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111437363A (en) * | 2020-05-10 | 2020-07-24 | 汤同兴 | External medicinal liquor for treating traumatic injury |
| CN112107644A (en) * | 2020-09-30 | 2020-12-22 | 广西环江瑶保康原生态养生有限公司 | Preparation method of Yao nationality antibacterial liquid |
| CN113069512A (en) * | 2021-04-15 | 2021-07-06 | 黑龙江左忆生物科技发展有限公司 | Traditional Chinese medicine composition for treating muscle and bone pain and corresponding acupuncture method |
| CN114832038A (en) * | 2022-05-24 | 2022-08-02 | 杨赛平 | Traditional Chinese medicine composition for treating arthralgia and myalgia and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110152205A1 (en) * | 2009-06-29 | 2011-06-23 | Nanchang University | Application of puerarin in the preparation of p2x3 mediated drugs for pain/nervous system diseases |
-
2019
- 2019-07-30 CN CN201910691850.3A patent/CN110292616A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110152205A1 (en) * | 2009-06-29 | 2011-06-23 | Nanchang University | Application of puerarin in the preparation of p2x3 mediated drugs for pain/nervous system diseases |
Non-Patent Citations (2)
| Title |
|---|
| 张淑卿 等主编: "《平乐正骨骨伤常见疾病健康教育》", 31 December 2018, 北京：中国中医药出版社 * |
| 陈其林: "中药熏蒸结合外敷治疗老年急性腰扭伤57例疗效观察", 《山西中医》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111437363A (en) * | 2020-05-10 | 2020-07-24 | 汤同兴 | External medicinal liquor for treating traumatic injury |
| CN112107644A (en) * | 2020-09-30 | 2020-12-22 | 广西环江瑶保康原生态养生有限公司 | Preparation method of Yao nationality antibacterial liquid |
| CN113069512A (en) * | 2021-04-15 | 2021-07-06 | 黑龙江左忆生物科技发展有限公司 | Traditional Chinese medicine composition for treating muscle and bone pain and corresponding acupuncture method |
| CN114832038A (en) * | 2022-05-24 | 2022-08-02 | 杨赛平 | Traditional Chinese medicine composition for treating arthralgia and myalgia and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110292616A (en) | The pharmaceutical composition and its application method for treating arthralgia and myalgia | |
| CN108553633A (en) | A kind of Dressed plaster and preparation method thereof for treating rheumatism and neck-shoulder pain, lumbago and leg pain | |
| CN106620622A (en) | Moxibustion composition and preparation method and application thereof | |
| CN105832947A (en) | Health-care foot-soaking Chinese herbal medicine powder | |
| CN107823280A (en) | A kind of Chinese medicine composition for treating pain and preparation method thereof | |
| CN102764275B (en) | A kind of external application Chinese medicine for the treatment of tumor and preparation method thereof | |
| CN101417059B (en) | Ointment for treating burn and scald and preparation method thereof | |
| CN100339122C (en) | Ointment for treating chronic osteitis | |
| CN104644928A (en) | Medicine for treating cervical and lumbar disc herniations | |
| CN110538272A (en) | swelling-reducing and collateral-dredging powder for treating soft tissue injury and joint swelling and pain and preparation method thereof | |
| CN111265644A (en) | Bone-activating pain-relieving plaster and preparation method thereof | |
| CN110151886A (en) | A kind of plaster for treating pain of neck, shoulder, waist and leg | |
| CN104491700A (en) | Externally-applied traditional Chinese medicine for treating rheumatism nervous arthralgia and preparation method of externally-applied traditional Chinese medicine | |
| CN109908245A (en) | It is a kind of for treating the Chinese medicine composition of neck-shoulder pain, lumbago and leg pain disease | |
| CN109568469A (en) | A kind of Chinese medicine ointment for treating scald and preparation method thereof | |
| CN103585257A (en) | Traditional Chinese medicine powder for treating fractures | |
| CN111760008B (en) | Externally applied osteoporosis medicine and its preparation | |
| CN107669842A (en) | Treat bruise knife wound, burn and anti-infectious traditional Chinese medicine for outer use and its production method | |
| CN105663832A (en) | Traditional Chinese medicine composition for treating radiodermatitis | |
| CN105998397A (en) | Traditional Chinese medicinal composition for treating paronychia | |
| CN106421255A (en) | Topical traditional Chinese composition and its application | |
| CN105902634A (en) | Plaster for treating pain of neck, shoulder, waist and leg | |
| CN106266153A (en) | A kind of for Chinese medicine composition dredging collaterals of human and preparation method thereof | |
| CN105617214A (en) | Traditional Chinese medicine composition for treating scabies | |
| CN105770034A (en) | Chinese herbal preparation for treating femoral head necrosis and preparing method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191001 |